GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Orthofix Medical Inc (FRA:OM2) » Definitions » Cyclically Adjusted Revenue per Share

Orthofix Medical (FRA:OM2) Cyclically Adjusted Revenue per Share : €24.14 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Orthofix Medical Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Orthofix Medical's adjusted revenue per share for the three months ended in Mar. 2024 was €4.598. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €24.14 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Orthofix Medical's average Cyclically Adjusted Revenue Growth Rate was 0.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.00% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Orthofix Medical was 16.20% per year. The lowest was -2.60% per year. And the median was 5.10% per year.

As of today (2024-05-28), Orthofix Medical's current stock price is €13.50. Orthofix Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €24.14. Orthofix Medical's Cyclically Adjusted PS Ratio of today is 0.56.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Orthofix Medical was 2.53. The lowest was 0.37. And the median was 1.36.


Orthofix Medical Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Orthofix Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthofix Medical Cyclically Adjusted Revenue per Share Chart

Orthofix Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.00 19.27 22.17 23.54 24.36

Orthofix Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.38 24.63 26.26 24.36 24.14

Competitive Comparison of Orthofix Medical's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Orthofix Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orthofix Medical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Orthofix Medical's Cyclically Adjusted PS Ratio falls into.



Orthofix Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orthofix Medical's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.598/131.7762*131.7762
=4.598

Current CPI (Mar. 2024) = 131.7762.

Orthofix Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 3.991 100.560 5.230
201409 4.175 100.428 5.478
201412 4.370 99.070 5.813
201503 4.428 99.621 5.857
201506 4.737 100.684 6.200
201509 4.780 100.392 6.274
201512 5.102 99.792 6.737
201603 4.724 100.470 6.196
201606 5.104 101.688 6.614
201609 4.774 101.861 6.176
201612 5.671 101.863 7.336
201703 5.343 102.862 6.845
201706 5.286 103.349 6.740
201709 4.754 104.136 6.016
201712 5.251 104.011 6.653
201803 4.671 105.290 5.846
201806 5.069 106.317 6.283
201809 5.158 106.507 6.382
201812 5.586 105.998 6.944
201903 5.032 107.251 6.183
201906 5.443 108.070 6.637
201909 5.436 108.329 6.613
201912 5.734 108.420 6.969
202003 4.915 108.902 5.947
202006 3.380 108.767 4.095
202009 4.857 109.815 5.828
202012 4.931 109.897 5.913
202103 4.542 111.754 5.356
202106 5.054 114.631 5.810
202109 4.834 115.734 5.504
202112 5.573 117.630 6.243
202203 4.856 121.301 5.275
202206 5.553 125.017 5.853
202209 5.731 125.227 6.031
202212 5.714 125.222 6.013
202303 4.579 127.348 4.738
202306 4.696 128.729 4.807
202309 4.629 129.860 4.697
202312 4.947 129.419 5.037
202403 4.598 131.776 4.598

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Orthofix Medical  (FRA:OM2) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Orthofix Medical's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=13.50/24.14
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Orthofix Medical was 2.53. The lowest was 0.37. And the median was 1.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Orthofix Medical Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Orthofix Medical's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Orthofix Medical (FRA:OM2) Business Description

Traded in Other Exchanges
Address
3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Orthofix Medical (FRA:OM2) Headlines

No Headlines